ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 696253 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 696253; 2) Community: the network communities that were significantly associated with the response to NSC 696253; 3) Molecule: the relationships between components within communities and NSC 696253; 4) MDR: the compounds that were significantly associated with the NSC 696253.

NSC Compound Enrichment Correlation
NSC 100880 Camptothecin 0.0352383000003056 0.14684625
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0352383000003056 0.26317257
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0352383000003056 0.33485796
NSC 18805 .gamma.-Thujaplicine 0.0352383000003056 0.36135442
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0352383000003056 0.58274656
NSC 303861 L-Cysteine analog 0.0352383000003056 0.50849158
NSC 321240 Null 0.0352383000003056 0.26714071
NSC 335995 Null 0.0352383000003056 0.288294
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0352383000003056 0.26006657
NSC 359239 Antibiotic X-14766A 0.0352383000003056 0.0040342235
Total:173  Current:130    [First] [Prev] [Next] [Last]